Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
National Institutes of Health has announced on 10 May 2022
that is accepting bids for the following project: Dissemination and Implementation Research in Health (R21 Clinical Trial Optional).
The tender will take place in United States
and will cover the Defence & Security industry.
The value of this project has not been disclosed by the donor and you can apply until Deadline date
After the deadline, Global Database will announce the contract award for Dissemination and Implementation Research in Health (R21 Clinical Trial Optional).
In order to stay
up-to-date with this tender and also to receive daily notifications about similar projects, you can subscribe to our
newsletter for free.
Bellow you can find more information about the tender description and the bidding procedure.
The purpose of this Funding Opportunity Announcement (FOA) is to support studies that will identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration, scale-up, and sustainability of evidence-based interventions, practices, programs, tools, treatments, guidelines, and policies. Studies that promote equitable dissemination and implementation of evidence-based interventions among underrepresented communities are encouraged. Conversely, there is a benefit in understanding circumstances that create a need to stop or reduce (de-implement) the use of practices that are ineffective, unproven, low-value, or harmful. In addition, studies to advance dissemination and implementation research methods and measures are encouraged. All applications must be within the scope of the mission of one of the Institutes/Centers listed above.